Clinical implications of discordance between low-density lipoprotein cholesterol and particle number

被引:283
作者
Otvos, James D. [2 ]
Mora, Samia [3 ,4 ]
Shalaurova, Irina [2 ]
Greenland, Philip [5 ,6 ]
Mackey, Rachel H. [7 ]
Goff, David C., Jr. [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC 27157 USA
[2] LipoScience Inc, Raleigh, NC USA
[3] Brigham & Womens Hosp, Dept Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
[7] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA
关键词
Cardiovascular disease risk; LDL cholesterol; LDL particle number; Lipoproteins; NMR; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; ATHEROSCLEROSIS; LDL; SIZE; PLASMA; RISK; SUBCLASSES; MANAGEMENT;
D O I
10.1016/j.jacl.2011.02.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: The amount of cholesterol per low-density lipoprotein (LDL) particle is variable and related in part to particle size, with smaller particles carrying less cholesterol. This variability causes concentrations of LDL cholesterol (LDL-C) and LDL particles (LDL-P) to be discordant in many individuals. METHODS: LDL-P measured by nuclear magnetic resonance spectroscopy, calculated LDL-C, and carotid intima-media thickness (IMT) were assessed at baseline in the Multi-Ethnic Study of Atherosclerosis, a community-based cohort of 6814 persons free of clinical cardiovascular disease (CV D) at entry and followed for CVD events (n = 319 during 5.5-year follow-up). Discordance, defined as values of LDL-P and LDL-C differing by percentile units to give equal-sized concordant and discordant subgroups, was related to CVD events and to carotid IMT in models predicting outcomes for a 1 SD difference in LDL-C or LDL-P, adjusted for age, gender, and race. RESULTS: LDL-C and LDL-P were associated with incident CVD overall: hazard ratios (HR 1.20, 95% Cl [CT] 1.08-1.34; and 1.32, 95% CI 1.19-1.47, respectively, but for those with discordant levels, only LDL-P was associated with incident CVD (HR 1.45, 95% CI 1.19-1.78; LDL-C HR 1.07,95% CI 0.88-1.30). IMTalso tracked with LDL-P rather than LDL-C, ie, adjusted mean IMT of 958, 932, and 917 mu m in the LDL-P > LDL-C discordant, concordant, and LDL-P < LDL-C discordant subgroups, respectively, with the difference persisting after adjustment for LDL-C (P = .002) but not LDL-P (P = .60). CONCLUSIONS: For individuals with discordant LDL-C and LDL-P levels, the LDL-attributable atherosclerotic risk is better indicated by LDL-P. (C) 2011 National Lipid Association. All rights reserved.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 29 条
[1]   Metabolic origins and clinical significance of LDL heterogeneity [J].
Berneis, KK ;
Krauss, RM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1363-1379
[2]   Multi-ethnic study of atherosclerosis: Objectives and design [J].
Bild, DE ;
Bluemke, DA ;
Burke, GL ;
Detrano, R ;
Roux, AVD ;
Folsom, AR ;
Greenland, P ;
Jacobs, DR ;
Kronmal, R ;
Liu, K ;
Nelson, JC ;
O'Leary, D ;
Saad, MF ;
Shea, S ;
Szklo, M ;
Tracy, RP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (09) :871-881
[3]   Lipoprotein management in patients with cardiometabolic risk - Consensus conference report from the American diabetes association and the American college of cardiology foundation [J].
Brunzell, John D. ;
Davidson, Michael ;
Furberg, Curt D. ;
Goldberg, Ronald B. ;
Howard, Barbara V. ;
Stein, James H. ;
Witztum, Joseph L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (15) :1512-1524
[4]   LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-Implications for LDL management [J].
Cromwell, William C. ;
Otvos, James D. ;
Keyes, Michelle J. ;
Pencina, Michael J. ;
Sullivan, Lisa ;
Vasan, Ramachandran S. ;
Wilson, Peter W. F. ;
D'Agostino, Ralph B. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2007, 1 (06) :583-592
[5]   Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol &lt;100 mg/dl [J].
Cromwell, William C. ;
Otvos, James D. .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (12) :1599-1602
[6]   Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study [J].
Deedwania, Prakash ;
Barter, Philip ;
Carmena, Rafael ;
Fruchart, Jean-Charles ;
Grundy, Scott M. ;
Haffner, Steven ;
Kastelein, John J. P. ;
LaRosa, John C. ;
Schachner, Holly ;
Shepherd, James ;
Waters, David D. .
LANCET, 2006, 368 (9539) :919-928
[7]   Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women - The EPIC-Norfolk Prospective Population study [J].
El Harchaoui, Karim ;
van der Steeg, Wim A. ;
Stroes, Erik S. G. ;
Kuivenhoven, Jan Albert ;
Otvos, James D. ;
Wareham, Nicholas J. ;
Hutten, Barbara A. ;
Kastelein, John J. P. ;
Khaw, Kay-Tee ;
Boekholdt, S. Matthijs .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (05) :547-553
[8]   Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence - The Multi-Ethnic Study of Atherosclerosis (MESA) [J].
Folsom, Aaron R. ;
Kronmal, Richard A. ;
Detrano, Robert C. ;
O'Leary, Daniel H. ;
Bild, Diane E. ;
Bluemke, David A. ;
Budoff, Matthew J. ;
Liu, Kiang ;
Shea, Steven ;
Szklo, Moyses ;
Tracy, Russell P. ;
Watson, Karol E. ;
Burke, Gregory L. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (12) :1333-1339
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]   When Should a New Test Become the Current Reference Standard? [J].
Glasziou, Paul ;
Irwig, Les ;
Deeks, Jonathan J. .
ANNALS OF INTERNAL MEDICINE, 2008, 149 (11) :816-W168